Stanley C. Erck
2012
In 2012, Stanley C. Erck earned a total compensation of $1.2M as President & CEO at Novavax, a 12% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $198,000 |
|---|---|
| Option Awards | $612,990 |
| Salary | $430,000 |
| Other | $1,357 |
| Total | $1,242,347 |
Erck received $613K in option awards, accounting for 49% of the total pay in 2012.
Erck also received $198K in non-equity incentive plan, $430K in salary and $1.4K in other compensation.
Rankings
In 2012, Stanley C. Erck's compensation ranked 5,289th out of 11,487 executives tracked by ExecPay. In other words, Erck earned more than 54.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,289 out of 11,487 | 54th |
Division Manufacturing | 1,852 out of 4,252 | 56th |
Major group Chemicals And Allied Products | 445 out of 1,200 | 63rd |
Industry group Drugs | 292 out of 922 | 68th |
Industry Biological Products, Except Diagnostic Substances | 51 out of 165 | 69th |
Source: SEC filing on April 30, 2013.
Erck's colleagues
We found four more compensation records of executives who worked with Stanley C. Erck at Novavax in 2012.